{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:47:12Z","timestamp":1765486032187,"version":"3.37.3"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000387","name":"Meningitis UK","doi-asserted-by":"publisher","award":["6015"],"award-info":[{"award-number":["6015"]}],"id":[{"id":"10.13039\/501100000387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K027131\/1"],"award-info":[{"award-number":["MR\/K027131\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160403","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T17:36:24Z","timestamp":1470764184000},"page":"e0160403","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345\/NEIS1825) Protein of Neisseria meningitidis"],"prefix":"10.1371","volume":"11","author":[{"given":"Mar\u00eda Victoria","family":"Humbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Chiu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Akoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Edward","family":"Heckels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"issue":"Suppl 2","key":"ref1","doi-asserted-by":"crossref","first-page":"B18","DOI":"10.1016\/j.vaccine.2012.01.062","article-title":"Meningococcal vaccine development\u2014from glycoconjugates against MenACWY to proteins against MenB\u2014potential for broad protection against meningococcal disease","volume":"30","author":"PM Dull","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"ref2","first-page":"431","article-title":"Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT","volume":"30","author":"H Findlow","year":"2013","journal-title":"AdvTher"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"ii","author":"J Finne","year":"1983","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from <italic>Neisseria meningitidis<\/italic>","volume":"27","author":"J Holst","year":"2009","journal-title":"Vaccine"},{"issue":"29","key":"ref5","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"MM Giuliani","year":"2006","journal-title":"Proc Nat Acad Sci USA"},{"key":"ref6","unstructured":"Bernfield L, Fletcher L, Howell A, Farley J, Zagursky R, Knauf M, et al. editors. Identification of a novel vaccine candidate for group B Neisseria meningitidis. Thirteenth International Pathogenic Neisseria Conference; 2002; Oslo, Norway. National Institute of Public Health, Oslo, Norway.2002."},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/MMBR.00056-12","article-title":"Role of Factor H binding protein in <italic>Neisseria meningitidis<\/italic> virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease","volume":"77","author":"LK Mcneil","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref8","article-title":"A randomized, controlled, phase 1\/2 trial of a <italic>Neisseria meningitidis<\/italic> serogroup B bivalent rLP2086 vaccine in healthy children and adolescents","author":"MD Nissen","year":"2012","journal-title":"PediatrInfect Dis J"},{"key":"ref9","unstructured":"Joint Committee on Vaccination and Immunisation website. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.gov.uk\/government\/groups\/joint-committee-on-vaccination-and-immunisation#publications-and-statements\" xlink:type=\"simple\">https:\/\/www.gov.uk\/government\/groups\/joint-committee-on-vaccination-and-immunisation#publications-and-statements<\/ext-link>. 2014."},{"issue":"9923","key":"ref10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(14)60226-9","article-title":"Group B meningococcal vaccine: recommendations for UK use","volume":"383","author":"AJ Pollard","year":"2014","journal-title":"Lancet"},{"key":"ref11","unstructured":"CDC website. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/meningococcal\/outbreaks\/vaccine-serogroupB.html\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/meningococcal\/outbreaks\/vaccine-serogroupB.html<\/ext-link>. 2014."},{"key":"ref12","article-title":"Meningococcal Serogroup B Bivalent rLP2086 vaccine elicits broad and robust serum bactericidal responses in healthy adolescents","author":"T Vesikari","year":"2015","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40259-015-0139-0","article-title":"Bivalent rLP2086 Vaccine (Trumenba((R))): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10\u201325 Years","volume":"29","author":"M Shirley","year":"2015","journal-title":"BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"U Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"JA Bettinger","year":"2013","journal-title":"Vaccine"},{"issue":"23","key":"ref16","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.vaccine.2015.04.015","article-title":"MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine","volume":"33","author":"D Medini","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"e116024","DOI":"10.1371\/journal.pone.0116024","article-title":"Progressive decrease in the potential usefulness of meningococcal serogroup B vaccine (4CMenB, Bexsero(R)) in Gipuzkoa, Northern Spain","volume":"9","author":"E Perez-Trallero","year":"2014","journal-title":"Plos One"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/IAI.00701-09","article-title":"Immunoproteomic analysis of the development of natural immunity in subjects colonized by <italic>Neisseria meningitidis<\/italic> reveals potential vaccine candidates","volume":"77","author":"JN Williams","year":"2009","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00608.x","article-title":"<italic>Neisseria meningitidis<\/italic> serogroup B: laboratory correlates of protection","volume":"34","author":"C Vermont","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1574-6968.2007.00893.x","article-title":"Deletion of <italic>peb4<\/italic> gene impairs cell adhesion and biofilm formation in <italic>Campylobacter jejuni<\/italic>","volume":"275","author":"H Asakura","year":"2007","journal-title":"Fems Microbiol Lett"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/81380","article-title":"Functional genomics of <italic>Neisseria meningitidis<\/italic> pathogenesis","volume":"6","author":"YH Sun","year":"2000","journal-title":"Nature Med"},{"article-title":"Role of the NMB0342-NMB0348 locus in meningococcal pathogenesis and investigation of NMB0345 as a vaccine candidate","year":"2004","author":"S Bakshi","key":"ref22"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/IAI.00397-13","article-title":"Transcriptional profiling of <italic>Neisseria meningitidis<\/italic> interacting with human epithelial cells in a long-term in vitro colonization model","volume":"81","author":"A Hey","year":"2013","journal-title":"Infect Immun"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"e5198","DOI":"10.1371\/journal.pone.0005198","article-title":"Host iron binding proteins acting as niche indicators for <italic>Neisseria meningitidis<\/italic>","volume":"4","author":"PW Jordan","year":"2009","journal-title":"PLoSOne"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/IAI.05019-11","article-title":"The <italic>Neisseria meningitidis<\/italic> Macrophage Infectivity Potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate","volume":"79","author":"MC Hung","year":"2011","journal-title":"Infect Immun"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/IAI.01424-06","article-title":"Proteomic analysis of outer membranes and vesicles from wild-type serogroup B <italic>Neisseria meningitidis<\/italic> and a lipopolysaccharide-deficient mutant","volume":"75","author":"JN Williams","year":"2007","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1099\/00221287-99-2-333","article-title":"The surface properties of <italic>Neisseria gonorrhoeae<\/italic>: isolation of the major components of the outer membrane","volume":"99","author":"JE Heckels","year":"1977","journal-title":"J Gen Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunisation with recombinant class 1 outer membrane protein from <italic>Neisseria meningitidis<\/italic>: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"M Christodoulides","year":"1998","journal-title":"Microbiol SGM"},{"issue":"2","key":"ref29","first-page":"e00041","article-title":"The Adhesin Complex protein of <italic>Neisseria meningitidis<\/italic> is a new adhesin with vaccine potential","volume":"4","author":"MC Hung","year":"2013","journal-title":"mBIO"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.1003623","article-title":"Novel blocking human IgG directed against the pentapeptide repeat motifs of <italic>Neisseria meningitidis<\/italic> Lip\/H.8 and Laz lipoproteins","volume":"186","author":"TD Ray","year":"2011","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: Scalable analysis of bacterial genome variation at the population level","volume":"11","author":"KA Jolley","year":"2010","journal-title":"Bmc Bioinformatics"},{"issue":"36","key":"ref32","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/j.vaccine.2015.07.032","article-title":"A putative amino acid ABC transporter substrate-binding protein, NMB1612, from <italic>Neisseria meningitidis<\/italic>, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins","volume":"33","author":"M-C Hung","year":"2015","journal-title":"Vaccine"},{"issue":"46","key":"ref33","doi-asserted-by":"crossref","first-page":"38383","DOI":"10.1074\/jbc.M508063200","article-title":"Biochemical and functional characterization of membrane blebs purified from <italic>Neisseria meningitidis<\/italic> serogroup B","volume":"280","author":"DMB Post","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B <italic>Neisseria meningitidis<\/italic> Delta gna33 mutant: Proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"G Ferrari","year":"2006","journal-title":"Proteomics"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/14789450.2014.938640","article-title":"<italic>Neisseria<\/italic> proteomics for antigen discovery and vaccine development","volume":"11","author":"M Christodoulides","year":"2014","journal-title":"Expert Rev Proteomics"},{"issue":"5459","key":"ref36","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"M Pizza","year":"2000","journal-title":"Science"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1586\/14760584.2015.1095638","article-title":"Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis\/trans isomerase (PPIase) proteins","volume":"14","author":"MaV Humbert","year":"2015","journal-title":"Expert Review of Vaccines"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:48:06Z","timestamp":1589024886000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160403"}},"subtitle":[],"editor":[{"given":"Caroline L","family":"Trotter","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160403","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}